Stock SEZI SENZIME AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Senzime AB

Equities

SEZI

SE0002478776

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:39 2024-04-26 am EDT 		5-day change 1st Jan Change
6.82 SEK +13.67% Intraday chart for Senzime AB +14.43% -8.21%
Apr. 26 Senzime Signs First Group Purchasing Organization Contract with Major US Hospital System as Sole Source Supplier CI
Apr. 24 Senzime Announces Major Public Tender Contract by the US Department of Veterans Affairs CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 954.6 1,500 1,425 750.6 889.4 816.4 - -
Enterprise Value (EV) 1 923.7 1,500 1,350 737.6 749.9 774.4 811.4 796.4
P/E ratio -26.8 x -28.6 x -17.4 x -5.4 x -5.12 x -7.66 x -23.5 x 26.2 x
Yield - - - - - - - -
Capitalization / Revenue 142 x - 130 x 53.5 x 24.9 x 10.2 x 4.11 x 2.34 x
EV / Revenue 138 x - 123 x 52.6 x 21 x 9.7 x 4.09 x 2.28 x
EV / EBITDA -38.5 x - -18.4 x -6.23 x -6.42 x -8.81 x -53.7 x 14.1 x
EV / FCF -29.8 x - - - -6.16 x -8.42 x -26.2 x 39.8 x
FCF Yield -3.35% - - - -16.2% -11.9% -3.82% 2.51%
Price to Book 5.53 x - 11.9 x 2.87 x 1.83 x 3.03 x 3.48 x 3.07 x
Nbr of stocks (in thousands) 52,448 62,493 62,493 69,884 119,706 119,706 - -
Reference price 2 18.20 24.00 22.80 10.74 7.430 6.820 6.820 6.820
Announcement Date 2/14/20 2/26/21 2/17/22 2/1/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6.711 - 10.98 14.03 35.75 79.8 198.5 349.4
EBITDA 1 -23.97 - -73.2 -118.4 -116.8 -87.9 -15.1 56.5
EBIT 1 -36.43 - -84.19 -133.9 -137.4 -109.5 -37.3 33.7
Operating Margin -542.86% - -766.77% -954.15% -384.18% -137.22% -18.79% 9.65%
Earnings before Tax (EBT) 1 -36.43 - -84.29 -134.4 -137.2 -107.9 -36.1 33.7
Net income 1 -33.68 -47.44 -82.14 -132.7 -141 -106.3 -34.8 31.6
Net margin -501.8% - -748.11% -945.56% -394.35% -133.21% -17.53% 9.04%
EPS 2 -0.6800 -0.8400 -1.310 -1.990 -1.450 -0.8900 -0.2900 0.2600
Free Cash Flow 1 -30.97 - - - -121.7 -92 -31 20
FCF margin -461.51% - - - -340.46% -115.29% -15.62% 5.72%
FCF Conversion (EBITDA) - - - - - - - 35.4%
FCF Conversion (Net income) - - - - - - - 63.29%
Dividend per Share - - - - - - - -
Announcement Date 2/14/20 2/26/21 2/17/22 2/1/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7.288 8.462 9.154 10.85 13.5 16.7 21.5 28.1
EBITDA 1 -26.46 -30.2 -25.48 -34.66 -26.1 -24.4 -18.5 -18.9
EBIT 1 -31.42 -35.26 -30.59 -40.09 -31.5 -29.8 -23.9 -24.3
Operating Margin -431.16% -416.65% -334.21% -369.46% -233.33% -178.44% -111.16% -86.48%
Earnings before Tax (EBT) 1 -31.69 -35.26 -30.59 -39.62 -31 -29.4 -23.5 -24
Net income 1 -30.8 -34.36 -30.17 -38.81 -30.6 -28.9 -23 -23.8
Net margin -422.65% -406.1% -329.63% -357.68% -226.67% -173.05% -106.98% -84.7%
EPS 2 - -0.4200 -0.3300 -0.3300 -0.3000 -0.2000 -0.2000 -0.2000
Dividend per Share - - - - - - - -
Announcement Date 4/28/23 8/24/23 10/26/23 2/15/24 - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 30.9 - 74.9 13 140 42 5 20
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -31 - - - -122 -92 -31 20
ROE (net income / shareholders' equity) -20.3% - -53.1% -64.3% - - - 13%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 3.290 - 1.910 3.750 4.070 2.250 1.960 2.220
Cash Flow per Share -0.5500 - - - - - - -
Capex 1 3.77 - - - 0.95 1 2 3
Capex / Sales 56.12% - - - 2.66% 1.25% 1.01% 0.86%
Announcement Date 2/14/20 2/26/21 2/17/22 2/1/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Senzime AB

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SENZIME AB Stock Senzime AB
-8.21% 74.46M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. SEZI Stock
  4. Financials Senzime AB